Charles Harbison Herndon

Charles Harbison Herndon, MD (September 23, 1915 – July 27, 1997) was an influential figure in the history of orthopaedic surgery and musculoskeletal medicine, revered for defining the foundational biological mechanisms of bone graft incorporation and whole-joint allograft transplantation, originating the Heyman-Herndon-Strong tarsometatarsal capsulotomy for resistant metatarsus adductus, pioneering clean-room laminar airflow engineering in joint arthroplasty, and providing transformative academic stewardship as long-standing chair of orthopaedics at Case Western Reserve University and President of the American Academy of Orthopaedic Surgeons, the Orthopaedic Research Society, and the American Board of Orthopaedic Surgery.

1. The Shoulders of Giants: Historical Context & Significance

The mid-twentieth century witnessed the transformation of orthopaedic surgery from an empirical, mechanically focused craft into an academically rigorous, basic science-grounded surgical specialty. In the immediate aftermath of World War II, musculoskeletal surgeons faced formidable biological limitations. Massive skeletal defects caused by high-energy combat trauma, osteomyelitis, and nonunions necessitated bone transplantation, yet bone grafting was guided largely by conflicting clinical impressions rather than cellular science. Surgeons debated whether graft osteocytes survived transplantation, whether grafts served merely as inert mineral struts, and why homologous bone (allografts) encountered alarming rates of nonunion, resorption, and failure compared to autografts. Whole-joint transplantation was widely regarded as a biological impossibility due to rapid host immunological rejection, articular cartilage breakdown, and subchondral bone collapse.

“If I have seen further, it is by standing on the shoulders of giants.”

Sir Isaac Newton (1675) / Bernard of Chartres

In pediatric orthopaedics, deformities such as severe, resistant metatarsus adductus and residual clubfoot forefoot adduction presented equally vexing challenges. Existing surgical remedies relied upon aggressive wedge resections or premature midfoot osteotomies that breached the cartilaginous anlagen of tarsal bones, producing lifelong midfoot stiffness, shortened feet, and premature degenerative arthritis. In joint arthroplasty, the dawn of modern prosthetic reconstruction was shadowed by catastrophic deep peri-prosthetic infection rates before the advent of engineered operating room airflow systems.

Dr. Charles Harbison Herndon fundamentally changed the trajectory of the specialty. Embodying the archetype of the modern surgeon-scientist, Herndon bridged the operating theatre and the biological laboratory. In collaboration with dental histologist Samuel W. Chase, DDS, PhD, Herndon unraveled the microscopic kinetics of osteogenesis, revascularization, and “creeping substitution” in bone grafts, and demonstrated the distinct immunologic and mechanical behavior of whole-joint allografts. Clinically, partnering with Clarence H. Heyman and Joseph M. Strong, he pioneered tarsometatarsal capsulotomy, an anatomical joint-sparing soft-tissue release that corrected rigid forefoot adduction without violating bony architecture. Furthermore, Herndon recognized that surgical excellence demanded institutional integrity; as President of the American Board of Orthopaedic Surgery, he championed the establishment of mandatory recertification and continuous competence. Modern orthopaedic surgeons utilizing structural allografts, joint-preserving pediatric releases, and laminar airflow operating suites walk the pathways forged by Herndon.

2. Early Life, Formative Education & Career Milestones

Education and Formative Surgical Training

Charles Harbison Herndon was born on September 23, 1915, in Dublin, Erath County, Texas. Raised in the rural heart of Texas, he cultivated a disciplined intellect and an affinity for the natural sciences. Herndon pursued his collegiate education at the University of Texas, where his academic distinction secured him admission to Harvard Medical School in Boston, Massachusetts. At Harvard, Herndon was immersed in rigorous pathophysiology and classical clinical examination, earning his Medical Degree (MD) in 1940.

Following graduation, Herndon moved to Ohio to begin a surgical internship at University Hospitals of Cleveland and Western Reserve University School of Medicine (1940–1941) under the mentorship of Dr. Carl H. Lenhart. His early surgical training was dramatically redirected by the escalation of World War II. Herndon was commissioned as an officer in the United States Army Medical Corps in 1941. Prior to the full mobilization of American ground forces in Europe, Herndon answered a call for volunteer surgeons to staff the American Hospital in Britain, established at the Churchill Hospital in Headington, Oxford, England.

At Oxford, Herndon served under Dr. Philip D. Wilson, Sr., the distinguished Surgeon-in-Chief of The Hospital for Special Surgery (HSS) in New York. Wilson had organized the unit to provide acute surgical care to wounded Allied soldiers and British civilians injured in the Blitz. This grueling experience treating complex high-velocity ballistic trauma, compound blast fractures, soft-tissue avulsions, and severe musculoskeletal sepsis proved formative. Herndon rose to the rank of Major, continuing his service in the European theater with the 3rd and 23rd Station Hospitals and the 2nd General Hospital. His wartime observations of bone graft failure and massive osteolysis instilled in him a lifelong commitment to musculoskeletal basic science.

Upon his military discharge in 1946, Herndon re-joined Dr. Philip D. Wilson, Sr. in New York City to complete formal orthopaedic surgery residency training at The Hospital for Special Surgery. Under Wilson’s demanding tutelage, Herndon refined his operative technique in reconstructive surgery, pediatric deformities, and joint pathology, completing his fellowship and residency in 1947.

Academic Appointments and Clinical Leadership

In 1947, Western Reserve University School of Medicine and University Hospitals of Cleveland recruited Herndon to return to Cleveland as the institution’s very first full-time academic orthopaedic surgeon. At the time, orthopaedic surgery operated as a small sub-division within the Department of Surgery. Herndon brought an ambitious vision: establishing a comprehensive orthopaedic department rooted in laboratory research, systematic clinical registries, and structured resident education.

In 1953, Herndon was appointed Director of the Division of Orthopaedic Surgery, succeeding his close friend and surgical collaborator, Dr. Clarence H. Heyman. Herndon served as department head for nearly three decades (1953–1982). Under his visionary guidance, the division flourished, establishing an independent Department of Orthopaedic Surgery and forging an internationally renowned pediatric orthopaedic service at Rainbow Babies and Children’s Hospital. Herndon recruited leading scientists and clinicians, creating multidisciplinary research teams that joined orthopaedic surgeons with dental histologists, immunologists, microbiologists, and biomechanical engineers.

In 1979, grateful colleagues, former residents, and philanthropic donors established the Charles H. Herndon Professorship of Orthopaedic Surgery at Case Western Reserve University, an endowed chair formally inaugurated in 1982 upon his retirement from the chairmanship. Herndon’s extensive cohort of trainees formed the Charles H. Herndon Alumni Society to perpetuate his educational ideals. Nationally, the Orthopaedic Research and Education Foundation (OREF) instituted the prestigious Charles H. Herndon Research Award, bestowed upon meritorious investigators conducting basic and translational musculoskeletal research.

Beyond his home institution, Herndon achieved unmatched governance leadership across American orthopaedics, serving as:

• President of the Orthopaedic Research Society (ORS, 1957): Championed the expansion of basic science peer review and interdisciplinary collaboration between biological scientists and clinical surgeons.
• President of the American Board of Orthopaedic Surgery (ABOS, 1964–1966): Served as the pivotal visionary who initiated the dialogue and structured framework for mandatory, time-limited certification and periodic board recertification, arguing that public trust required continuous proof of surgical competence.
• President of the American Academy of Orthopaedic Surgeons (AAOS, 1967–1968): Guided the Academy through an era of explosive surgical subspecialization, total joint development, and expanded continuing medical education.
• President of the Association of Orthopaedic Chairmen (AOC, 1975): Standardized academic residency curricula and defended research funding across American medical schools.
• Trustee of The Journal of Bone and Joint Surgery (JBJS, 1969–1974): Stewarded the editorial and financial governance of the premier journal in musculoskeletal surgery.

Dr. Herndon retired as Professor Emeritus in 1982. He passed away on July 27, 1997, at the age of 81, remembered as one of the most consequential academic leaders in twentieth-century orthopaedics.

3. Core Orthopaedic Breakthroughs, Eponymous Signs & Innovations

Dr. Charles H. Herndon left a lasting legacy characterized by basic science investigations that transformed bone transplantation biology and clinical techniques that modernized pediatric foot and hip reconstruction.

Hallmark Anatomical, Diagnostic and Operative Contributions

• The Heyman-Herndon-Strong Tarsometatarsal Mobilization / Capsulotomy (1958): Designed alongside Clarence H. Heyman and Joseph M. Strong, this classic surgical procedure resolved the long-standing dilemma of severe, resistant congenital metatarsus adductus and residual forefoot adduction following clubfoot correction. Prior interventions frequently utilized midfoot wedge resections or premature osteotomies that damaged the developing tarsal bones and arrested growth. The Heyman-Herndon technique mobilized the metatarsal bases by performing complete surgical capsulotomies of all five tarsometatarsal (Lisfranc) and intermetatarsal joints, preserving the cartilaginous anlagen and longitudinally aligning the rays while protecting the first metatarsal physis.
• Biological Kinetics of Bone Graft Incorporation and Creeping Substitution (1955): In a landmark 1955 monograph with Samuel W. Chase, Herndon provided the definitive historical and experimental review of autogenous and homogenous bone grafting. They categorized the cellular kinetics of graft incorporation, demonstrating that while the vast majority of cellular elements in cortical and cancellous grafts perish upon transplantation, autografts provide both an osteoconductive scaffolding and inductive stimulus for host neovascularization and osteoclastic resorption, followed by new osteoid deposition (“creeping substitution”).
• Experimental Studies in Whole-Joint Allograft Transplantation (1952): Collaborating with Samuel W. Chase, Herndon executed pioneering canine knee joint transplantations. Their experiments revealed the remarkable immunological dichotomy of musculoskeletal allografts: articular cartilage survived with intact viable chondrocytes due to the avascular, proteoglycan-rich extracellular matrix shielding cells from host immune surveillance, whereas the vascularized subchondral bone stimulated aggressive host cell-mediated rejection that led to subchondral collapse if revascularization failed.
• Immunological Factors in Homogenous Bone Transplantation (1956): Conducting serological and cellular studies with Peter H. Curtiss Jr., Herndon demonstrated that fresh homologous bone grafts induce both humoral antibody formation and cell-mediated immune responses in host animals. They showed that physical processing methods, particularly deep freezing and lyophilization (freeze-drying), markedly diminished graft antigenicity, enabling successful incorporation of banked bone allografts.
• Heyman-Herndon Epiphysiodesis for Slipped Capital Femoral Epiphysis (1954): Together with Clarence H. Heyman, Herndon demonstrated the efficacy of open bone peg epiphysiodesis across the proximal femoral physis for adolescent slipped capital femoral epiphysis (SCFE). This biological fusion approach arrested progressive slip displacement, stimulated early physeal closure, and minimized the catastrophic risk of avascular necrosis and chondrolysis associated with forceful manipulative reductions.
• Anterior Tibialis Transposition for Paralytic Talipes Calcaneus (1956): Formulated with Strong and Heyman, this tendon transfer addressed dynamic muscle imbalance in paralytic calcaneus deformities resulting from poliomyelitis. Transferring the active anterior tibialis tendon through the interosseous membrane into the calcaneus restored active plantarflexion, stabilized the posterior hindfoot lever arm, and prevented progressive calcaneocavus deformity.
• Clean-Room Operating Environments and Laminar Airflow Engineering: Working with bioengineers and hospital epidemiologists at University Hospitals of Cleveland, Herndon was an early American pioneer in installing and validating vertical laminar airflow enclosures and body exhaust suits for joint replacement surgery. His clinical trials demonstrated profound reductions in deep surgical site infections during primary and revision arthroplasty.
• Visionary Architect of Mandatory Orthopaedic Recertification: As President of the ABOS (1964–1966) and AAOS (1967–1968), Herndon articulated the philosophical imperative that medical licensure and specialty board certification could not remain lifelong, unmonitored privileges. In his celebrated 1969 presidential address, “The Challenge to Orthopaedics—1969,” he called for institutional self-regulation, time-limited certificates, and mandatory recertification, establishing the foundation for modern continuous professional maintenance.

Biomechanical Mechanics, Tissue Biology & Surgical Principles

The scientific contributions of Charles H. Herndon linked clinical operative techniques with basic biomechanical and cellular principles. In the surgical management of resistant metatarsus adductus, the mechanical deformity consists of medial deviation of all five metatarsals relative to the lesser tarsus, creating a convex lateral foot border and a deep medial skin crease. In the toddler and young child, the cuneiforms, cuboid, and bases of the metatarsals are composed largely of radiolucent cartilaginous anlagen. Standard osteotomies through unossified or partially ossified cartilage carried grave risks of iatrogenic physeal arrest, dorsal bunion formation, and premature synostosis.

Herndon and his colleagues recognized that the deformity was maintained not by primary osseous synostosis, but by rigid capsular, ligamentous, and soft-tissue contractures tethering the tarsometatarsal (Lisfranc) complex. The second metatarsal base is anatomically recessed into a bony mortise between the medial and lateral cuneiforms, acting as the rigid mechanical “keystone” of the midfoot arch. In the Heyman-Herndon procedure, the surgeon systematically divides the dorsal, intermetatarsal, and plantar ligaments across all five joints, as well as the dense Lisfranc ligament connecting the medial cuneiform to the base of the second metatarsal. Crucially, the release preserves the plantar fascia and the naviculocuneiform and calcaneocuboid joint capsules, maintaining the structural stability of the longitudinal arch. Once fully mobilized, the metatarsals can be passively aligned into neutral abduction and transfixed with Kirschner wires. By avoiding osseous resection, this technique allows the cartilaginous anlagen to remodel physiologically under normal weight-bearing stresses.

In skeletal transplantation biology, Chase and Herndon dismantled prevailing dogmas regarding the fate of transplanted bone. Through meticulous histological analysis across canine and human specimens, they clarified that transplanted autogenous cortical and cancellous bone experiences nearly universal cellular necrosis; only a slender fraction of superficial osteocytes and lining cells on graft surfaces survive via immediate diffusion of host interstitial fluid. Incorporation of the graft depends entirely on host-mediated repair. Host capillary sprouts accompanied by perivascular mesenchymal stem cells and osteoclasts penetrate the graft haversian and Volkmann canals, progressively resorbing necrotic bone while depositing a layer of viable new osteoid upon dead trabecular scaffolding. This process of “creeping substitution” is biologically complete in cancellous autografts within months, whereas dense cortical autografts remain an admixed mosaic of viable new bone and necrotic structural matrix for years.

When examining homologous bone (allografts), Herndon and Curtiss demonstrated that graft failure was primarily immunological. Fresh allografts provoke a vigorous host immune response driven by cellular and marrow antigens, triggering perivascular lymphocytic infiltration, vascular thrombosis, and host osteoclast activation without reciprocal osteoblast apposition. This immune barrier halts creeping substitution, resulting in graft sequestration, nonunion, or late fatigue fracture. Herndon proved that physical pre-treatment of allografts, specifically deep-freezing at minus seventy degrees Celsius or lyophilization, denatures cellular membrane glycoproteins and human leukocyte antigens (HLA) while leaving the inorganic mineral scaffolding intact. This reduced graft antigenicity, enabling the host to incorporate banked structural allografts without intense immunologic rejection.

In whole-joint allografts, Herndon and Chase unraveled why articular cartilage withstands transplantation while underlying bone fails. Chondrocytes reside embedded inside a dense, negatively charged extracellular matrix rich in aggregated aggrecan proteoglycans and type II collagen. This avascular matrix acts as a biological filter: small nutrient molecules diffuse freely to nourish chondrocytes, while large host immunoglobulins, complement factors, and cytotoxic T-lymphocytes are physically excluded. Thus, articular cartilage possesses “immune privilege.” In contrast, the subchondral bone is highly vascular and antigenic, triggering rapid host rejection, avascular necrosis, and mechanical microfracture that undermines the overlying cartilage. Herndon’s discoveries established the fundamental biological rules that govern modern osteochondral allograft transplantation and deep-frozen bone banking today.

4. Master Class Pro-Tip

When performing the Heyman-Herndon tarsometatarsal capsulotomy for severe, resistant metatarsus adductus, surgical success requires strict protection of the dorsal neurovascular structures and meticulous release of the deep Lisfranc ligaments. Utilize two longitudinal dorsal incisions: a medial incision centered over the first and second tarsometatarsal joints, and a lateral incision over the fourth and fifth joints. Meticulously identify and retract the dorsal cutaneous branches of the superficial peroneal nerve and preserve the dorsalis pedis artery as it plunges plantarly between the first and second metatarsal bases. Elevate full-thickness periosteal flaps directly off the tarsometatarsal joints; never dissect into the subcutaneous fat plane.

The critical step of the release is mobilizing the recessed base of the second metatarsal from its cuneiform mortise. Divide the dorsal, plantar, and interosseous Lisfranc ligaments under direct visualization using a small, curved beaver blade or fine osteotome, taking care not to violate the articular cartilage of the intermediate cuneiform or the proximal growth physis at the base of the first metatarsal. Ensure that the naviculocuneiform and calcaneocuboid articulations remain undisturbed. Following complete capsular mobilization, gently abduct the forefoot into anatomical alignment. Transfix the first and fourth or fifth metatarsals across into the tarsus with smooth longitudinal Kirschner wires to prevent dorsal subluxation during cast immobilization. In bone grafting biology, remember Herndon’s cardinal lesson: graft incorporation is dictated by host biology. Always rigorously decorticate the host recipient bed down to punctate bleeding (“paprika sign”), stabilize structural allografts with rigid internal compression to safeguard fragile capillary sprouts during creeping substitution, and augment structural scaffolds with autologous cancellous bone or bone marrow aspirate to deliver viable host osteoprogenitors.

Master Class Surgical Pearl: Tarsometatarsal Mobilization and Biological Principles of Bone Grafting

5. Primary Landmark Publications & Bibliography

The foundational contributions of Charles Harbison Herndon, MD are preserved in these original landmark monographs and peer-reviewed surgical literature:

• Chase SW, Herndon CH. The fate of autogenous and homogenous bone grafts. A historical review. J Bone Joint Surg Am. 1955;37-A(4):809-841. doi:10.2106/00004623-195537040-00012. [DOI] [PubMed]
• Herndon CH, Chase SW. Experimental studies in the transplantation of whole joints. J Bone Joint Surg Am. 1952;34-A(3):564-580. doi:10.2106/00004623-195234030-00009. [DOI] [PubMed]
• Heyman CH, Herndon CH, Strong JM. Mobilization of the tarsometatarsal and intermetatarsal joints for the correction of resistant adduction of the fore part of the foot in congenital club-foot or congenital metatarsus varus. J Bone Joint Surg Am. 1958;40-A(2):299-310. doi:10.2106/00004623-195840020-00005. [DOI] [PubMed]
• Curtiss PH Jr, Herndon CH. Immunological factors in homogenous-bone transplantation. I. Serological studies. J Bone Joint Surg Am. 1956;38-A(1):145-148. doi:10.2106/00004623-195638010-00010. [DOI] [PubMed]
• Herndon CH, Strong JM, Heyman CH. Transposition of the tibialis anterior in the treatment of paralytic talipes calcaneus. J Bone Joint Surg Am. 1956;38-A(4):751-760. doi:10.2106/00004623-195638040-00004. [DOI] [PubMed]
• Herndon CH. The Challenge to Orthopaedics—1969. J Bone Joint Surg Am. 1969;51-A(2):397-400. doi:10.2106/00004623-196951020-00021. [DOI] [PubMed]
• Mostofi SB. Charles Harbison Herndon 1915–1997. In: Mostofi SB, ed. Who’s Who in Orthopedics. London: Springer-Verlag; 2005:136-138. doi:10.1007/1-84628-070-2_104. [DOI]
• In Memoriam: Charles H. Herndon, M.D. 1915–1997. J Bone Joint Surg Am. 1998;80-A(2):457-458. doi:10.2106/00004623-199802000-00021. [DOI]

6. Biographical Provenance & Acknowledgments

This historical biography was synthesized for the OrthopaedicsOne Knowledge Network as part of A Who’s Who of Orthopaedics, adapted and expanded from the foundational biographical directory Who’s Who in Orthopedics (Springer-Verlag London) edited by Seyed B. Mostofi, BSc, MBBS, FRCS (Ed).